There are simple steps our patients can take can take that could go a long way in reducing their overall toxic burden. These steps, combined with diligent efforts to limit the uptake of toxins--whether pollutants, pesticides or heavy metals—can and should be a part of anyone’s overall health maintenance and disease prevention strategy.
One of the key features of LD is the broad impairment of the affected individual’s innate immune response. The usual process of phagocytosis and lysosome recycling does not occur properly. Without improved immune defense and repair functions, the remissions obtained with antibiotics alone will seldom be more than fleeting.
There's a lot of talk these days about following an "alkaline" diet as a way of restoring health and prolonging life. In principle a lot of the core ideas behind this approach make good physiological sense.
It is a basic fact of physiology that the efficiency of any biochemical pathway is limited by the chemical substrate that is most essential and least available. This is known as Von Liebig's Law of Limiting Substances, and as clinicians we would do well to keep it in mind.
Anthropologists and medical historians agree: Healthier people consume about equal amounts of Omega-3 and Omega-6 fats. This is true for all cultures, ethnic groups and geographies that have been studied. In industrial societies like ours, Omega 3s, which soothe and repair, tend to be low in peoples' diets while Omega 6s, which activate and inflame, are high.
Though it is most often thought of as the body's defense department, the immune system also serves many important repair functions, identifying and neutralizing foreign substances and repairing the body's tissues from daily wear and tear.
In 1968, Dr. Kilmer McCully, a Harvard researcher, reported that a genetic defect that caused sharp elevations in homocysteine led to early, aggressive atherosclerosis and coronary heart disease. This was the first of many studies that pointed to homocysteine as an independent risk factor for heart disease.
To make good clinical use of the last half-century's scientific study of inflammation, we need to re-think inflammation and understand it more correctly as a repair deficit--something blocking the innate ability of the body to heal.
Hemoglobin A1c (HgbA1c) is one of the most useful and important biomarkers available to us as clinicians. It accurately predicts the risk of diabetes long before the disease advances, and it can be used to assess the impact of any form of therapy aimed at regulating blood sugar and insulin sensitivity.